Solventum is expected to release its fiscal fourth-quarter earnings soon, and analysts project a modest earnings increase.

Solventum MEDITECH Expanse Accelerator partnership integrates AI to streamline clinical documentation and reduce clinician administrative burden.

Fintel reports that on January 20, 2026, Mizuho upgraded their outlook for Solventum (NYSE:SOLV) from Neutral to Outperform.

Mizuho also upgraded Envista to Neutral from Underperform, citing improving demand trends and market share gains in higher-margin products. It said recent survey results and company performance ...

It’s been almost a year since Solventum spun off as a separate business from 3M. Now, Solventum is orchestrating a spinoff of its own. On Tuesday, Solventum announced that it has lined up a deal to ...

Get the live share price of Solventum Corp. (SOLV), including intraday charts, historical performance, key financials, and ...

Solventum, 3M’s health care spinoff based in Maplewood, is exploring a sale of its purification and filtration business, the Wall Street Journal reported Thursday citing unnamed sources. Solventum’s ...

Solventum Corp. closed 10.16% short of its 52-week high of $88.20, which the company reached on December 2nd.

With a market cap of $11.5 billion, Solventum Corporation (SOLV) is a U.S.-based healthcare company that was spun off from 3M on April 1, 2024. Headquartered in Maplewood, Minnesota, Solventum focuses ...

On Tuesday, Thermo Fisher Scientific Inc. (NYSE:TMO) agreed to acquire Solventum’s (NYSE:SOLV) Purification & Filtration business for approximately $4.1 billion in cash. Solventum’s Purification & ...